ICI-182780 associated with longer remission duration than megestrol in resistant breast cancer Dec. 22, 1997
Gensia pursues formation of Metabasis as separate company and announces Sankyo investment Dec. 22, 1997
Isolation, structural elucidation and preliminary biological evaluation of new XOD inhibitor Dec. 22, 1997